If you feel your psoriasis treatment is not producing what you seek here are 10 key factors that might be hindering your ...

A 40-year-old Hispanic man presented for treatment of dermatitis on his elbows ... A clinical diagnosis was made of psoriasis and he was prescribed clobetasol propionate ointment with salicylic ...

Psoriasis is a tricky disease to manage ... an aryl hydrocarbon receptor agonist and the first FDA-approved steroid-free topical medication in its class. Two months later, Arcutis won approval ...

Topical ruxolitinib cream shows promise as a treatment for inflammatory skin conditions, but lacks consistent data, indicating a need for further research into its use across various dermatologic ...

Although manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...

ZORYVE foam is a once-daily, steroid-free topical and is now widely available as a treatment for plaque psoriasis. Nearly 9 million people in the United States are living with plaque psoriasis ...

Get Instant Summarized Text (Gist) The FDA has approved Zoryve (roflumilast) 0.3% topical foam for once-daily treatment of plaque psoriasis on the scalp and body in patients aged 12 and older ...

(Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the U.S. Food and Drug Administration (FDA) has ...

Trusted, comprehensive information about this skin condition.

Bagel. Chances are that your doctor will have you try topical treatments for scalp psoriasis first, like salicylic acid. You can also find scalp psoriasis shampoos, gels, oils, lotions ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

1. Arcutis’ Zoryve (roflumilast) topical foam 0.3% approved by US FDA for the treatment of plaque psoriasis in adults and adolescents ages 12 and older. Arcutis Biotherapeutics. News release.